08893338falsePharmaceutics2023-03-012024-02-28http://www.companieshouse.gov.uk/2023-02-28http://www.companieshouse.gov.uk/cd:Director12023-03-012024-02-28http://www.companieshouse.gov.uk/cd:AuditExemptWithAccountantsReport2023-03-012024-02-28http://www.companieshouse.gov.uk/pt:CurrentFinancialInstruments2024-02-28http://www.companieshouse.gov.uk/pt:CurrentFinancialInstruments2023-02-28http://www.companieshouse.gov.uk/2023-03-012024-02-28http://www.companieshouse.gov.uk/2023-02-28http://www.companieshouse.gov.uk/2024-02-28http://www.companieshouse.gov.uk/cd:FullAccounts2023-03-012024-02-28http://www.companieshouse.gov.uk/cd:PrivateLimitedCompanyLtd2023-03-012024-02-28http://www.companieshouse.gov.uk/cd:Micro-entities2023-03-012024-02-28iso4217:GBPxbrli:sharesxbrli:pure
Registered number: 08893338

OP Pharma Ltd

ACCOUNTS
FOR THE YEAR ENDED 28/02/2024

Prepared By:
Avalon Partners Ltd
35 Watling St Rd
Preston
PR2 8EA

OP Pharma Ltd

Registered Number: 08893338
BALANCE SHEET AT 28/02/2024
20242023
££
Current assets26,65610,565
Creditors: amounts falling due within one year(6,156)(6,342)
Net Current Assets20,5004,223
Total assets less current liabilities20,5004,223
Accruals and deferred income570537
Net Assets19,9303,686
Capital and reserves19,9303,686
Average Number of Employees
During the year the average number of employees was 1.
Company information
Private company limited by shares registered in EW - England and Wales, registered number 08893338. Registered office 39 Hill Street, Wednesbury, West Midlands, WS10 9LD, UK
For the year ending 28/02/2024 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the provisions applicable to companies subject to the micro-entities regime.
These accounts have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.
Approved by the board on 27/11/2024 and signed on their behalf by
.............................
Omar Patel
Director